CEDAX

This brand name is authorized in Mexico, South Africa

Active ingredients

The drug CEDAX contains one active pharmaceutical ingredient (API):

1 Ceftibuten UNII 62F4443RWP - CEFTIBUTEN DIHYDRATE

Ceftibuten is a semisynthetic, beta-lactamase-stable, third-generation cephalosporin with antibacterial activity. Ceftibuten binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. This results in the weakening of the bacterial cell wall and causes cell lysis. Read about Ceftibuten

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CEDAX Capsule / Oral suspension	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DD14	Ceftibuten	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 019M94, 020M94
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/20.1.1/0217, 27/20.1.1/0218, 27/20.1.1/215, 27/20.1.1/216